Cite
Rangachari D, VanderLaan PA, Le X, et al. Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice. Cancer Treat Commun. 2015;4:174-181doi: 10.1016/j.ctrc.2015.10.004.
Rangachari, D., VanderLaan, P. A., Le, X., Folch, E., Kent, M. S., Gangadharan, S. P., Majid, A., Haspel, R. L., Joseph, L. J., Huberman, M. S., & Costa, D. B. (2015). Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice. Cancer treatment communications, 4174-181. https://doi.org/10.1016/j.ctrc.2015.10.004
Rangachari, Deepa, et al. "Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice." Cancer treatment communications vol. 4 (2015): 174-181. doi: https://doi.org/10.1016/j.ctrc.2015.10.004
Rangachari D, VanderLaan PA, Le X, Folch E, Kent MS, Gangadharan SP, Majid A, Haspel RL, Joseph LJ, Huberman MS, Costa DB. Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice. Cancer Treat Commun. 2015;4:174-181. doi: 10.1016/j.ctrc.2015.10.004. PMID: 26601054; PMCID: PMC4653729.
Copy
Download .nbib